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Abstract. Type I collagen is expressed in a variety of
connective tissue cells and its transcriptional regula-
tion is highly complex because of the influence of
numerous developmental, environmental, and hor-
monal factors. To investigate the molecular basis for
one aspect of this complex regulation, the expression
of al(I) collagen (COLIA1) gene in osseous tissues,
we fused a 3.6-kb DNA fragment between bases
-3,521 and +115 of the rat COLIA1 promoter, and
three deletion mutants, to the chloramphenicol
acetyltransferase (CAT) marker gene. The expression
of these CoICAT transgenes was measured in stably
transfected osteoblastic cell lines ROS 17/2.8, Py-la,
and MC3T3-El and three fibroblastic lines NIH-3T3,
Rat-1, and EL2. Deletion of the distal 1 .2-kb fragment
of the full-length CoICAT 3.6 construct reduced the
promoter activity 7- to 30-fold in the osteoblastic cell
lines, twofold in EL2 and had no effect in NIH-3T3
and Rat-1 cells. To begin to assess the function of
COLIAI upstream regulatory elements in intact
animals, we established transgenic mouse lines and
T
YPE I collagen is the predominant component of the
extracellular matrix and is synthesized by a variety of
connective tissue cells. The protein is encoded by
two genes, al(I) (COL1A1)' and a2(I) collagen (COLIA2),
which are expressed and regulated in a coordinated fashion.
Although the regulation oftype I collagen genesis not as dra-
maticas other highly inducible genes, the control of their ex-
pression is extremely complex. Both are single copy non-
housekeeping genes which are active in distinctly different
connective tissue cells (Ramirez and Di Liberto, 1990) in-
cluding: interstitial cells that produce skin, tendon, and the
framework of all organs and connective tissues of the body;
smooth muscle cells of blood vessels and other viscera; car-
tilage cells, in which a different RNA start site is utilized
1. Abbreviations used in this paper: CAT, chloramphenicol acetyltransfer-
ase; COL1À1, al(1) collagen; COLIA2, a2(1) collagen; PTH, parathyroid
hormone; TK, thymidine kinase; vitamin D, 1,25-dihydroxyvitamin D3.
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examined the activity of the CoICAT3.6 construct in
various tissues of newborn animals. The expression of
this construct followed the expected distribution be-
tween the high and low collagen-producing tissues :
high levels of CAT activity, in calvarial bone, tooth,
and tendon, a low level in skin, and no detectable ac-
tivity in liver and brain. Furthermore, CAT activity in
calvarial bone was three- to fourfold higher than that
in the adjacent periosteal layer. IJ*munostaining for
CAT protein in calvaria and developing tooth germ of
CoICAT3.6 mice also confirmed the preferred expres-
sion of the transgene in differentiated osteoblasts and
odontoblasts compared to fibroblast-like cells of peri-
osteum and dental papilla. This study suggests that the
3.6-kb DNA fragment confers the strong expression of
COLIAI gene in high collagen producing tissues of in-
tact animals and that the 5' flanking promoter se-
quence between -3,521 and -2,295 by contains one
or more stimulatory elements which are preferentially
active in osteoblastic cells.
(Bennett and Adams, 1990); activated fibroblastic cells that
are involved in tissue repair and fibrosis; and osteoblasts and
odontoblasts which form a mineralized matrix. Each cell
type demonstrates characteristic regulation of these genes
under a variety ofdifferent circumstances. Examples include
activation of type I collagen genes at a specific time during
development; modulation of type I collagen production dur-
ing growth or in response to mechanical force; reduction of
collagen synthesis in bone cells during periods of mineral
deprivation through the actions of calcitrophic hormones
1,25-dihydroxyvitamin D3 (vitamin D) and parathyroid hor-
mone (PTH)' ; and activation of the gene during inflamma-
tion and repair in all cell types.
Most published experiments concerning the transcrip-
tional control of transfected type I collagen promoter con-
structs have used fibroblastic cells. These studies mapped the
regions responsible for regulation of COL1A1 and COLIA2
promoters by local growth factors (Choe et al ., 1987; Rossi
227and de Crombrugghe, 1988), systemic hormones (Walsh et
al., 1987) and viral transformation (Liau et al., 1985). A
number of cis-acting elements from the 5' promoter region
and trans-acting factors involved in transcriptional regula-
tion of type I collagen genes have been described (for review
see Ramirez and Di Liberto, 1990; Vuorio and de Chrom-
brugghe, 1990) . These include the COLIAl and COUA2
promoter sequences which control the tissue-specific expres-
sion in transfected cells (Boast et al., 1990; Karsenty and de
Crombrugghe, 1990; Rippe et al., 1989; Schmidt et al .,
1986) and in transgenic animals (Khillan et al ., 1986; Slack
et al ., 1991), inhibition in oncogene-transformed fibroblasts
(Schmidt et al., 1985), nuclear factor 1-binding sequence
which mediates stimulation by transforming growth factor-O
(Rossi and Crombrugghe, 1988) and CCAAT box-binding
nuclear factor which was identified and purified from fibro-
blastic cells (Hatamochi et al., 1986; Maity et al., 1988) .
Furthermore, regulatory elements have been identifiedwithin
the first intron which can have either strong stimulatory, in-
hibitory or neutral effect on the activity of COLIA1 and
COUA2 promoters (Bornstein and McKay, 1988; Rippe et
al., 1989; Rossi and de Crombrugghe, 1987; Rossouw et al.,
1987; Sherwood and Bornstein, 1990; Slack et al., 1991).
In addition to those control mechanisms which are as-
sumed to operate in many fibroblastic cell lines, there is
growing evidence that there must be other regulatory mecha-
nisms which are unique for the cells producing osseous tis-
sue, osteoblasts, and odontoblasts. First, .osteoblasts have a
higher basal rate ofcollagen synthesis than fibroblastic cells.
This conclusion is based on the rates of collagen synthesis
measured in embryonic tissues (Diegelmann and Peter-
kofsky, 1971; Moen et al., 1979), primary cell cultures (Lu-
ben et al ., 1976; McCarthy et al ., 1988; Wong, 1982), and
fetalrat calvariae in organculture (Canalis, 1980; Rowe and
Kream, 1982) . Second, fully differentiated osteoblasts pro-
duce almost exclusively type I collagen, while fibroblasts
make a variety of colla en types (I, III, IV, V, and VI) (Fess-
ler et al ., 1981; Liau dt al., 1985; Olsen et al., 1989; Pih-
lajaniemi et al., 1989). Third, the synthesis oftype I collagen
in osteoblasts from fetalrat calvariae and cultured osteosar-
coma cells is regulated by several hormones such as vitamin
D, PTH (Kream et al ., 1980; Lichtler et al., 1989; Rowe and
Kream, 1982), insulin (Kream et al., 1985), and insulin-like
growth factor-I (Canalis, 1980), whereas periosteal fibro-
blasts do not respond to these hormones. Finally, in the
MOV13 mouse, a retroviralinsertion in the first intron of the
COUA1 gene completely blocks its transcription in fibro-
blasts but does not inhibit its activity in odontoblasts and os-
teoblasts (Kratochwil et al., 1989). This observation sug-
gests that odontoblasts and osteoblasts use cis-active DNA
sequences within the COUA1 gene that are different from
those used in fibroblasts and which are capable of overriding
the inhibitory effect of retroviral insertion.
We have recently isolated an upstream 3.6-kb rat COLlAl
promoter fragment and studied its expression and hormonal
regulation in clonal rat osteosarcoma cell line ROS 17/2.8
and EL2 fibroblasts (Lichtler et al ., 1989). In the present
study we used several transfected osteoblastic and fibroblas-
tic cell lines to identify regions within the COLIA1 3.6-kb
promoter fragment involved in transcriptional regulation of
this gene in osseous tissue. The results indicate that the se-
quence between -3,521 and -1,672 of the COLIAl pro-
moter has a greater stimulatory effect on transcription of the
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transgene when expressed in osteoblastic versus fibroblastic
cell lines and suggests the presence of transcription control
elements in the COLIA1 promoter 5' flanking sequence that
are differentially used in osteoblasts compared to fibroblasts.
When introduced into transgenic animals, the regulatory
elements within the full length CoICAT3.6 chimeric gene
were sufficient for augmented expression in high type I
collagen-producing tissues.
Materials andMethods
7kansfection ofOsteoblastic andFibroblastic
CellLines
A variety of immortalized osteoblastic cell lines were selected for transfec-
tion studies because they each express some of the characteristics of the
fully differentiated osteoblast. The clonal rat osteosarcoma cell line ROS
17/2.8 (Majeska et al., 1978) synthesizes type I collagen, osteocalcin, and
alkaline phosphatase, has vitamin D and PTH receptors and produces
mineralized tumors in vivo. MC3T3-El is a mouse calvaria osteoblastic cell
line which mineralizes in culture and has a PTH-responsive adenylate cy-
clase (Suda et al., 1983). Py1A cells (Lichtier, A. C., B. E. Kream, D. W
Rowe, G. Carmichael, and R. Majeska. 1987. J. BoneMin. Res. 25:125)
synthesize type I collagen and alkaline phosphatase and respond to cortisol,
insulin-like growth factor-I, and vitamin D (B. E. Kream, unpublished
data). The fibroblastic lines NIH3T3, Rat-1 (Zarbl et al., 1987), and E12
(Liboi et al., 1984) were used as a nonosseous cell source. All cells were
maintained in F-12 medium supplemented with nonessential amino acids,
4 mM glutamine, 100 U/ml penicillin, 100 pg/ml streptomycin, and 10%
FCS in a humidified atmosphere of 5 or 7.5% CO2.
To produce stably transfected lines, cells were plated at 3-4 x 10° cells/
cmz in either 60- or 100-mm tissue culture dishes and cotransfected the
next day with 4-6,ug ofone ofthe CoICAT DNA constructs (described be-
low) and one tenth that amount ofpSV2neo (Gorman et al., 1983), using
either the calcium phosphateprecipitationor Lipofectin(Bethesda Research
Laboratories, Gaithersburg, MD) method. 6 h after addition of the DNA/
calcium phosphate complex, the cells were shocked with 1.5 ml of 15%
glycerol in 1x Hepes-buffered saline for 1 min. The cells were subsequently
washed in PBS and placed in F-12 medium containing 10% FCS. The Lipo-
fectin-mediated transfections were carried out in serum-free F-12 medium,
which was replaced 14-18 h later with F-12 containing 10% FCS. With ei-
ther method, the cells were split at a 1:3 ratio the following day and placed
under selection with 400 pg/ml ofthe G-418 (Geneticin; Gibco Laborato-
ries, Grand Island, NY). 3 to 5 wks later 50-900 colonies of cells carrying
the same construct were pooled, expanded, and assayed for CAT activity
or collagen synthesis.
Collagen PromoterConstructs
CoICAT3.6 contains a 3.6-kb fragment of the rat COUA1 gene between
bases -3,521 and +115, fused to the CAT marker gene (Lichtier et al.,
1989). Deletion mutants ofthis parental construct (see Fig. 2) were cloned
by using naturally occurring restriction sites. CoICAT2.3 and CoICAT1.7
deletion mutants, extending from -2,295 and -1,672 by upstream of the
RNA start site, were cloned after cutting CoICAT3.6 with HindIII and PstI,
respectively, and self ligating the ends. To clone the CoICAT0.9 mutant
(-944to +115 bp), the 1,062-bp PvuII-Xbal fragment was first cloned into
the XbaI/Hincü site of Puc19 from which the Xbal/HindIII fragment was
then ligated into pUCCAT 13 (Lichtier et al., 1989).
To test for a potential transcriptional activity of COLIA1 upstream
regulatory elements on a heterologous promoter, a 2112 by XbaI/ApaI
genomic fragment was inserted upstream ofthe herpes simplexvirus thymi-
dine kinase (TK) minimal promoter (bases -109 to +151) within the plas-
mid prE1 (Edlund et al., 1985). The Xbal/Apai fragment spans between
bases -3,521 and -1,408 and thus includesall ofthe sequences ofthe Xbal/
Pstl fragment. Before insertion, the 598-bp spacer between the BamHI site
and Nrul site was removed from pTEI, bringing the polylinker closer to the
TK promoter.
Assays ofCollagen Synthesis andCATActivity
Either two 60-mm plates or one 100-mm plate was used per assay point.
Cells were grown to confluency and fresh medium containing 5 ACi/ml
[5?H]proline and 50 pg/ml ascorbic acid was addedto the culture medium
22824 h before harvesting. Radiolabeled collagen and noncollagenous proteins
were assayed (Diegelmannand Peterkofsky, 1971) fromthe culture medium
(Kreamet al ., 1986) as a measure of endogenous collagen gene expression.
The percent collagen in the medium was corrected for the relative abun-
dance of proline in collagen compared to noncollagen protein.
The cell layerwas harvested forthe CAT assay by scraping in buffer con-
taining 0.04 M Tris-HCI, pH 7.4, 1 mM EDTA, and 0.15 M NaCl, cen-
trifuged, and by resuspending the cell pellet in 100 Al of0.25 M Tris-HCI,
pH 7.8. After disrupting the cells by three cycles of freezing and thawing,
aliquots of the cell extract containing the indicated amounts of protein
(Bradford, 1976) or DNA (Brunk et al., 1979) were assayed for CAT activ-
ity as described previously (Gorman et al., 1982). The assay mixture con-
tained 0.46 M Tris, pH 7.8, and 50 ACi/mmol [1,2-14C] chloramphenicol
in a final reaction volume of 150 Al. The volume ofextract was selected to
produce conversion within the linear range ofthe CAT assay. The reaction
was started by addition of 4 mM acetyl-CoA and carried out at 37°C for
4-6 h. The acetylated chloramphenicol products were separated by thin
layerchromotography onasilica gel plate (Baker-Flex IB2; J. T. Baker Inc.,
Phillipsburg, NJ), visualized by autoradiography, and the intensity of the
spots was quantitated by either scintillation spectrometry or by using Betagen
Betascope 603 (Betagen Corporation, Waltham, MA) blot analyzer. The
diffusion CAT assay was performed as described (Sambrook et al., 1989).
SouthernBlotAnalysis
Genomic DNA was prepared from stably transfected cell populations or tis-
sues from transgenic animals as described previously (Padula et al., 1988).
DNA was restricted with EcoRI or Pvull, separated on a 1% agarose gel,
transferred to a nylonmembrane (Zetabind; Cund Inc., Meriden, CT), and
hybridized as described (Singh and Jones, 1984), except for the following
modifications: the transfer was doneby capillary blotting and the hybridiza-
tion contained as additional components 10% dextran sulfate, 30% forma-
mide, 0.1% Sarkosyl instead of sodium dodecyl sulfate, and 0.1 mg/ml
salmon sperm DNA. DNA fragments were labeled by the random primer
method (Feinberg and Vogelstein, 1983). Two approaches were used to de-
termine the copynumber ofthetransgene incorporated in stably transfected
cells or transgenic animals. In the first, a 1.4-kb EcoRI fragment encoding
the CAT and SV-40 sequences present in the transfected vectors was hybrid-
ized to EcoRI-digested genomic DNA and the copy number was calculated
by comparison to cloned CATcontaining DNA standards. The second ap-
proach was designed to detect both the transfected and endogenous collagen
gene by hybridizing the PvuH-XbaIpromoter fragment (-944 to +115 bp)
to PvuII-digested genomic DNA. Hybridization to the endogenous gene
producedabandof2.6kb, whilethetransfected construct produced a 1.2-kb
band. The amount of radioactivity in the hybridized bands was quantitated
using a Betagen Betascope 603 blot analyzer.
Analysis ofRansgenic Mice
Transgenic mice were produced by microinjection (Hogan et al., 1986) of
CoICAT3.6construct linearized by FspI (line 1), or DNA fragment obtained
by digestion with HaeII of CoICAT3.6 and purified by agarose gel elec-
trophoresis. Each HaeII restriction fragment contained the CoICAT hybrid
gene and about 200 by of flanking vector sequence. The transgenic founder
animals, as well as subsequent breeders, were identified by dot blot hybrid-
ization for the CAT gene. Genomic DNA was denatured in 0.2 M NaOH,
neutralized with HC1 and 6x SSC, spotted on nylon membrane (Zetabind;
CundInc.) by using dot blot apparatus(Schleicher and Schuell, Inc., Keene,
NH), hybridized with the same 1.4-kb CAT probe, and quantitated as de-
scribed above.
To prepare tissue extracts for CAT assays, various tissues from 3- to
5-d-old progeny of either heterozygote or homozygote breeders were ho-
mogenized using a Polytron in 0.5 ml of buffer (250 mM Tris-HCI, 1 mM
EDTA, and 1 mM PMSF), and sonicated for 20 s (setting 4). At this point,
an aliquot of each sample was taken for DNA content analysis and the re-
mainder of sample was centrifuged at 12,000 g for 30 min at 4°C. The su-
pematant of each tissue extract was then assayed for the expression of CAT
reporter gene. In indicated experiments,analiquotofeach sample was used
for protein assay. In some experiments, dissected calvarial halves were in-
cubated in the collagen cross-linking inhibitor ß-aminopropionitrile and
24 h later the periosteum was stripped from the central.bone using a fine
scalpel blade (Rowe and Kream, 1982). In other experiments, mandibular
first molar tooth germs were dissected from 4- or 5-d-old mice and homog-
enized as described above.
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LightMicroscopy andImmunofluorescence
Calvaria and tooth germs werefixed for 1 h at 4°C in 1% paraformaldehyde
and 1.25% glutaraldehyde in0.1 M cacodylatebuffer, pH 7.4, postfixed with
1% OsO4, dehydrated in a graded series of ethanols followed by propylene
oxide and embedding in Polybed (Polysciences Inc., Warrington, PA).
Thick sections (1-21cm) were cut with a glass knife and stained with 0.01%
toluidine blue and 1% sodium borate. For immunofluorescence, calvariae
were fixed with 5 % paraformaldehyde and 2% sucrose in 0.1 M cacodylate
buffer, pH 7.4, for 1.5 h on ice, washed extensively in 2% sucrose in the
same buffer, drained, and frozen in liquid nitrogen. Tooth germs were fixed
overnight in 95% ethanol at 4°C, fully dehydrated, and embedded in
paraffin. Cryostat sections (calvariae) or deparaffinized sections (tooth
germs) were reacted with a 1:20 dilution of rabbit antibody against CAT (5
Prime - 3 Prime Inc., West Chester, PA) for 1 h, rinsed with PBS, and in-
cubated with a 1:100 dilution of rhodamine- or fluorescein-conjugated goat
anti-rabbit IgG (Chemicon, El Segunda, CA) for 1 h, and washed. Control
sectionswere only treated with thesecond antibody. Sections were mounted
in 2.5% n-propyl gallate in PBS:glycerol and observed with an Optiphot
fluorescence microscope (Nikon, Inc., Garden City, NY).
RNaseProtection
Isolation oftotal RNA was performed as described (Chomczynski and Sac-
chi, 1987). The RNase protection probe was a Tagl-EcoRl fragment of
CoICAT3.6 which extends from -269 by in the collagen promoter, includes
115 by of COLIA1 mRNA, to +256 by in the CAT gene (see Fig. 8). Hy-
bridization of this probe to collagen CAT mRNA produced by the trans-
fected DNA protects a 371-bp band, while hybridization to the endogenous
collagen mRNA protects a 115-bp band. This fragment was cloned into
pBS+ and transcribed with T7 RNA polymerase in the presence of CI-32P
UTP to produce a uniformly labeledantisense probe. The probe was mixed
with 512g total cellular RNA, precipitated with ethanol, hybridized in 80 %
formamide, 0.4 M NaCl, 40 mM Hepes, pH 7.6, and 2 mM EDTA at 50°C
overnight, and digested as described (Hart et al., 1985), except thatwe used
a crude preparation ofT2 and TI ribonucleases which we have foundtogive
equivalent resultsto purified T2 (Lichtler et al., 1991). Total volumeofeach
reaction mixture was phenol/chloroform extracted, ethanol precipitated,
electrophoresed on an 8% polyacrylamide gel containing 8 M urea, and
bands were revealed by autoradiography.
Results
To determine if the 5' flanking sequences of the rat COLIA1
promoter are preferentially active in osteoblastic versus
fibroblastic cell lines, four Co1CAT constructs and the neo-
mycin resistance plasmid pSV2neo were cotransfected into
three osteoblastic (ROS 17/2 .8, Py-la, and MC3T3-El) and
three fibroblastic cell lines (NIH-3T3, EL2, and Rat-1) . The
cell populations which emerged from the antibiotic selec-
tion, containing either stably integrated COICAT3.6 or one
of the deletion mutants, maintained their osteoblastic or
fibroblastic phenotype as judged by morphological criteria,
and in the case of the osteoblastic cells, the response to dexa-
methasone (Hodge and Kream, 1988), PTH, and vitamin D
(Kream et al., 1986; data not shown) . A representative CAT
assay, shown in Fig. 1, compares the activity ofthe COICAT3.6
construct and three deletion mutants in ROS17/2.8 and NIH-
3T3 cells. The strength of expression of COICAT3.6, as com-
pared to CoICAT2 .3, is not fully appreciated in ROS 17/2 .8
line, because the activity is beyond the linear range of the
CAT assay.
The quantitative results of CAT assays from a number of
experiments and the percent collagen synthesized by the cell
population are summarized in Fig. 2 . In ROS 17/2.8 cells,
the deletion of sequences upstream of the HindIll site
(-2,295 bp) caused a sevenfold decrease in CAT activity.
Deletion of the next fragment (between -2,295 and -1,672
bp) resulted in another sevenfold decrease in activity. Thus,
there was a 50-fold difference in activity between the most
229Figure 1. Representative assay forCAT activity of the four COLlA1
promoter constructs in stably transfected cells ROS 17/2.8 and
NIH-3T3 . Equal amounts of protein from the cell extracts (85 hg
from ROS 17/2.8 and 70 Ag from NIH-3T3) were added to each
reaction . The expression of the full-length CoICAT3 .6 construct in
ROS 17/2 .8 cells was beyond the linear range of the CAT assay.
active and the least active construct in ROS 17/2.8 cells. In
contrast, the NIH-3T3 and Rat-1 cells showed no significant
difference in the CAT expression between the four con-
structs, while in EL2 cells deletion from -3,521 to -2,295
by produced only a twofold decrease in activity. The lack of
a stimulatory element in the 5' upstream sequences of the
COL1A1 gene in NIH-3T3 cells, which we found here, has
been observed by two other research teams (Rippe et al .,
1989 ; Stacey et al ., 1988) . The results from two other os-
teoblastic cell lines, Py-la, and MC3T3-El (Fig. 3), which
were obtained by using diffusion CAT assay, showed that the
CAT activity of the CoICAT3.6 was reduced 10 and 27-fold
in Py-la and MC3T3-El, respectively, after deletion of se-
quences upstream to -2,295 bp . Unlike in ROS 17/2 .8, all
of the stimulatory activity was located between -2,295 and
-3,521 by in both the Py-la and MCM-El cells. In sum-
mary, deletion of sequences between -3,521 and -1,672 by
had a significant effect onCAT activity in all three osteoblas-
tic cell lines, but had no comparable effect on activity of
fibroblastic lines .
To ensure that the changes in the activity of the deletion
constructs did not reflecta difference in the ability ofthe cells
to transcribe the collagen promoter brought on by the trans-
fection and cell selection process, the level of endogenous
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NIH 3T3
￿
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￿
EL2
Figure 2. Summary of the results ofCAT expression and endoge-
nous collagen production by the cell lines stably transfected with
four COLIA1 promoter constructs . The CAT activity was assayed
by thin layer chromatography, as described in Materials and
Methods, and expressed as the percentage of total chloramphenicol
converted to acetylated derivatives per mg protein from the cell ex-
tract . Each value is the mean from 3 to 20 CAT assay points from
1 to 4 different cell populations, as shown in Table I. The values
are normalized to the expression ofCoICAT3 .6 inROS 17/2.8 cells,
which was taken as 100% . Collagen synthesis (% col) is expressed
as the percent oftotal radiolabeled protein secreted into the culture
medium .
collagen synthesis was measured in most of the cell lines .
The percent collagen in the medium (Fig . 2) was similar for
the cell populations of the same cell line, regardless of the
transgene carried in the genome. Furthermore, the copy
number of the chimeric gene in the stably transfected cell
populations was analyzed by Southern blots in most of the
cell populations. Comparison of average CAT expression in
any particular cell population with the transgene copy num-
ber is shown in Table I . These data indicate that there was
no correlation between the expression and the copy number
of the transgene in these stably expressing cells.
There was little correlation between the relative levels of
expression of the endogenous gene and the transgene be-
tween the cell types . This was particularly true for ROS
17/2.8 and NIH-3T3 lines. Radiolabeled collagen accumu-
lated in the culture media was comparable (10-14% ROS
17/2.8, 9-10% NIH-3T3) . However, thefull-length transgene
was expressed seven times higher in ROS 17/2 .8, while ex-
Py-1 a
￿
MC3T3-Ei
Figure 3 . CAT expression in two osteoblastic cell lines stably trans-
fected with four COLIA1 promoter constructs, measured by the
diffusion CAT assay. The CAT activity (expressed as cpm/ ug pro-
tein/h) was normalized to the expression of the CoICAT3.6 con-
struct in each cell type, which was taken as 100% . The level ofen-
dogenous collagen synthesis, which was determined by measuring
the percent collagen in the culture medium, did not vary within the
cell lines of the same phenotype containing different CoICAT con-
structs (not shown) .
CoICAT Construct
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CAT
100
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9
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CAT
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w CoICAT2.3
60 CoICAT1 .7
r
a CoICAT0.9 U
40
ó 20
0Table I . CATActivityand CopyNumber ofthe Transgene in Stably Transfected Cell Populations
* Stably transfected cell population derived from independent transfection .
$ CAT activity is expressed as the percent of chloramphenicol conversion per 10 jug of protein from the cell extract .
¢ Not done .
pression of the two shortest promoter fragments was four- to
fivefold higher in NIH-3T3 than in ROS 17/2 .8. In the Rat-1
and EL2 cells, which accumulated substantially less colla-
gen in culture medium, the expression of the full-length
transgene was similar to the activity of the two shortest pro-
moter fragments in ROS 17/2 .8 cells .
We next examined if the stimulatory elements located be-
tween bases -3,521 and -1,672 are active when fused to a
heterologous promoter. The XbaIApaI fragment from the
CoICAT3 .6 was inserted in both positive and negative orien-
tation upstream ofthe minimalTK promoter within the pTE1
vector, after removal of 598-bp fragment from pBR322 be-
tween the TK promoter and polylinker cloning sites . Previ-
Figure 4. Stimulation of a heterologous promoter by COLIA1 up-
stream regulatory elements . Three stably transfected populations
of ROS 17/2 .8 cells were produced as described in methods . The
CAT activity, expressed as in Fig . 2 and normalized to construct
pTElApBRXA-, represents an average expression from -350
(pTEIApBR), 900 (pTElApBRXA+), and 800 (pTElApBRXA-)
pooled colonies oftransfected cells . XbaI/ApaI genomic fragment
from COLIAl was inserted into the plasmid liTEIApHR in positive
(pTEIABRXA+) or negative (pTElApBRXA'-) orientation .
Pavlin et al . Utilization of COLIAI Promoter
ous studies with theTK promoter region between -109 and
+151 by showed higher stimulation by a heterologous en-
hancerwhen thepBR322 spacer was removed (Edlund et al .,
1985) . Fig . 4 shows that the XbaIApaI fragment stimulated
the activity of the TK promoter 10-fold in ROS 17/2.8 cells
in an orientation independent manner, which is typical for
most enhancer elements .
Figure 5. The CAT activity in tissues of transgenic mice from line
2 carrying the CoICAT3.6 chimeric gene . 2 gg of protein from tis-
sue extract was applied to each reaction . The calvarial sample in
this experiment contained both central calvarial bone and its adja-
cent periosteum . In subsequent experiments, shown in Fig . 5 and
Tkble I, calvarial bone, and periosteum were assayed for CAT as
separate samples .
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ROS 17/2 .8
Copy
Tx* CAT* No . Tx
EL2
CAT
Copy
No .
NIH-3T3
Tx CAT
Copy
No . Tx
Py-la
CAT
Copy
No .
MC3T3
Tx CAT
copy
No . Tx
Ratl
CAT
copy
No .
Transgene
18/1 168 48 221,/1 35 5 231,/1 15 9 Py3 .6 22 11 MC3.6 12 64 29/1 3 9
CoICAT3 .6 18/2 123 23 22/1 46 nd
19/1 60 36 22/2 47 nd
19/2 46 4
18/3 21 8 22L/3 8 16 23L/3 14 12 Py2 .3 2 .1 21 MC2.3 0 .5 43 29/4 2 9
CoICAT2 .3 18/4 2 2 22L/4 8 8 23L/4 11 17 29/5 2 14
19/3 26 9 22/3 17 nd 29/6 2 15
CoICATI .7 18/5 2 9 22L/5 10 nd 23L/5 16 25 Pyl .7 3 25 MC1 .7 0.2 6 29/7 2 16
19/2 1 3 22/5 31 nd
CoICAT0 .9 18/6 3 17 22L/6 2 nd 23L/6 14 33 Py0 .9 4 13 MC0.9 0 .5 9 29/8 3 11
18/7 3 nd 22L/7 0.5 nd 23L/7 9 29 29/9 4 17
22/6 29 nd
22/7 33 ndTableH. CATActivity in Tissues of Transgenic Mice
Carrying CoICAT3.6 Construct
* Number of animals per litter.
$ CAT activity is expressed as the percent of chloramphenicol conversion per
100 ng DNA and each number represents the mean value of measurements
from individual animals or pools ofanimals . The litters from line 1 were from
heterozygous transgenic parent and extracts from each tissue were pooled in
one (Tg3) or four groups of three to four animals each (Tg4), with unknown
ratio of transgenic versus wild type animals in each group . Both litters from
line 2 were from homozygous transgenic parent and, therefore, contained only
transgenic animals .
4 Not done .
Although cultured bone cells provide a useful model sys-
tem for analyzing tissue-specific expression, these cells are
not fully differentiated osteoblasts and thus may not demon-
strate the complete spectrum of gene regulation found in os-
teoblasts of an intact animal . Therefore, to examine the ex-
pression of the transgene in various animal tissues, two
separate transgenic mouse lines were established carrying
theCoICAT3 .6 construct . A representative experiment com-
paring the CAT expression in various tissues of transgenic
mice from line 2 is shown in Fig . 5 . High levels of expression
were found in COLIA1-producing tissues of whole calvaria,
tooth germ, and tendon, while there was no detectable activ-
ity in liver and brain . Quantitative data from several experi-
ments using both mouse strains are summarized in Table II .
The high level of CAT expression was found in calvarial
bone, tooth, and tendon, with significantly lower activity in
skin and no activity in liver and brain .
Since osteoblasts of the rat calvariae produce three- to
fourfold more collagen than adjacent periosteal tissue (Rowe
and Kream, 1982), CAT activity in central bone osteoblasts,
and periosteum was compared . A similar difference should
also exist in the activity of the full-length CoICAT3 .6 con-
Figure 6. The CAT activity in central calvarial bone and the adja-
cent periosteum of the transgenic mice line 2 . An aliquot of the
sample containing 0.4 pg ofDNA was assayed . The litter was ran-
domly divided in four groups of three to four pups . Since the
breeder was heterozygous for the CAT transgene, the proportion of
transgenic animals in each pool varied, hence the differences in
CAT expression between the groups . B, central bone ; P, peri-
osteum.
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struct in the transgenic mice if the transgene contains the
control elements responsible for osseous tissue-preferred
transcription . As shown in Fig . 6 and Table II, the CAT ex-
pression in central bone from 5-d-old mouse calvariae from
the transgenic lines 1 and 2 was three- to fourfold higher as
compared to that in calvarial periosteum .
The differential expression of the CoICAT3.6 transgene in
osseous versus fibroblastic cells was also detected in calvar-
iae from the transgenic mouse line 2 stained with an anti-
body against CAT (Fig . 7) . Although immunoreactivity was
seen in periosteal fibroblasts, osteoblasts lining the newly
formed osteoid surface demonstrated considerably higher
staining intensity (Fig . 7 b) . The developing tooth germ is
a highly polarized structure composed of undifferentiated
precursor cells of dental papilla and polygonal, highly
differentiated odontoblasts which underlie the mineralizing
dentin (Fig. 7 d) . Immunostaining was considerably higher
in odontoblasts as compared with the cells of the dental
papilla (Fig . 7 e) .
RNase protection experiments were performed to ensure
that the mRNA transcripts of the CAT gene are initiated at
the proper start site . The cRNA probe used is expected to
protect the fragments of 371 nt and 115 nt when hybridized
to the transcripts of transfected chimeric gene and endoge-
nous collagen gene, respectively. As shown in a representa-
tive experiment in Fig . 8, the transcripts ofthe CoICAT chi-
meric gene were correctly initiated in both stably transfected
cell populations and in transgenic mice . Although both ex-
tracts contained equivalent amounts of collagenmRNA, the
level of transgene mRNA was higher in transgenic animals
than in transfected cells .
Discussion
Our approach to identify cis-active elements which control
type I collagen genes in bone was to characterize the activity
of collagen promoter DNA constructs in bone-derived and
fibroblastic cell lines . Multiple cell lines representative of
osseous and nonosseous cells were examined because of the
heterogeneity inherent to various lines . Subsequently, the
ability of the longest promoter construct to confer differen-
tial regulation in low and high collagen producing cells was
confirmed in intact tissues of transgenic animals .
The results of our functional analysis ofdeletion mutants
ofCoICAT3.6 construct suggest the presence oftranscription
stimulatory DNA sequences that are preferentially used by
osteoblasts and odontoblasts and located between -3,521
and -1,672 by in the rat COL1A1 promoter. In osteoblastic
cell lines ROS17/2.8, Py-la, and MC3T3-El, a 7-25-fold
difference in expression between the CoICAT3.6 and Col-
CAT2.3 constructs was observed (Figs . 2 and 3) . The same
deletions did not cause any changes in the promoter activity
in NIH3T3 or Rat-1 cells and caused only twofold decrease
in EL2 cells . This suggests that a sequence between -3,521
and -1,672 by is active primarily in osteoblastic cells. The
lack of the effect of deletions on promoter activity in NIH-
3T3 and Rat-1 cells is consistent with the results from other
laboratories . Transient transfection studies inNIH-3T3 fibro-
blasts (Rippe et al ., 1989) revealed only negative regulatory
elements upstream from -222 by inthemouseCOUA1 pro-
moter. Studies using stably transfected mouse fibroblasts
showed that sequences upstream of -1,000 by in the mouse
232
Line
Copy
No . Litter n* Bone
Calvaria
Periost . Tooth Tend . Skin Liver Brain
1 6 Tg3 7 127t nd§ 387 59 nd 0 0
Tg4 13 124 34 nd nd nd nd nd
2 15 Tg7 7 45 17 nd 11 2 0 0
Tg12 7 63 nd 21 25 2 0 0COL1A1 promoter have no effect on transcription (Stacey et
al ., 1988) . We decided to use stably transfected cell popula-
tions because our initial results from transiently transfected
ROS17/2.8 and fibroblastic lines, although suggesting bone-
preferred stimulatory sequences in the upstream promoter,
were quite variable. We believe that the variability resulted
from the competing requirements of rapidly dividing cells
needed for high transfection efficiency and slower dividing
higher density cells for expression ofthe osteoblastic pheno-
type(Owen et al., 1990) . Once the permanently transfected
Pavlin et al. Utilization of COLIA1 Promoter
Figure 7 . Visualization ofCAT
immunoreactivity in differen-
tiated osteoblasts and odonto-
blasts from 5-d-old transgenic
mice carrying the Co1CAT
3 .6 chimeric gene. (a and d)
Light micrographs of a sec-
tion through calvaria (a) and
developing mandibular first
molar (d) . Osteoblasts (OB)
and odontoblasts (OD) are ob-
served adjacent to a layer of
mineralized matrix (M) . (P)
Periosteum ; (DP) dental pa-
pilla . (b and e) Immunofluo-
rescence micrographs ofsimi-
lar sections from calvaria (b)
and tooth (e) . Specific immu-
noreactivity (arrows) is visi-
ble in osteoblasts and odon-
toblasts . (c and f) Negative
controls (second antibody
only) of similar sections dem-
onstrating lack of specific im-
munoreactivity. Bar, 20 jAm .
cell populations were established, transgene activity could
be examined repeatedly, even after a cycle of cryopreserva-
tion, without a significant change in transgene activity.
The enhancing activity was distributed between the two
distal deletion fragments in ROS 17/2.8, while in the other
two osteoblastic cell lines it resided only within the most dis-
tal fragment . This may be a result of the presence of one or
more enhancer element within the HindIII-PstI fragment
(-2,295 to -1,672), which is active in ROS17/2.8 but not
in any other of the cell lines we examined . We have evidence
233Figure 8. RNase protection of endogenous COLIAl mRNA and
transgene mRNA . The 640 nt probe between the Taq I (T) and
EcoRl (E) restriction sites was prepared and labeled as described
in Materials and Methods . The entire reaction mixture containing
5 Wg of total cellular RNA was applied to the gel . The expected
bands of 115 and 371 nt, corresponding to the protected fragments
from the endogenous and transgenemRNAs respectively, were ob-
served when the probe was hybridized to RNA from ROS 17/2.8
cells (ROS) stably transfected with the Co1CAT3 .6 hybrid gene and
RNA from the calvaria (Calv) ofthe transgenic mice line 2, bearing
the CoICAT3 .6 gene . These bands were not present when the same
probe was hybridized tototal yeastRNA (yRNA) . The 640-ntband,
observed in this experiment in calvarial sample, may represent ei-
ther undigested probe or a minor upstream transcript . The latter
possibility is unlikely because this band has been an inconsistent
finding in other experiments using this and othercell and transgenic
lines. (M) DNA size markers ; (2,3) COLIA1 exons ; (PA) polyade-
nylation sequence.
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that the HindIH-PstI fragment contains the domain that
mediates the inhibitory effect of vitamin D on the COLIA1
promoter activity (Pavlin, D., A . C . Lichtler, J. Angily,B . E .
Kream, and D. W Rowe. 1989. J . Bone Min. Res. 4S:412) .
Analyses of other steroid hormone elements with down-
regulating activity indicate that in the absence ofthe ligand,
the element could act as a stimulator ofthe gene (Levine and
Manley, 1989) . Addition of the steroid hormone results in in-
hibition of the gene by repressing the element and reducing
the activity to the baseline level . Therefore, the vitamin D
response element may account for some of the enhancing ac-
tivity of the HindIH-PstI fragment in ROS 17/2.8 cells .
The full-length CoICAT3 .6 construct was expressed seven-
fold higher in ROS 17/2 .8 than in NIH-3T3 cells, despite the
fact that the endogenous collagen synthesis was similar be-
tween the two cell types . Thismay be becausethe CoICAT3.6
lacks some ofthe sequences necessary formaximum expres-
sion in NIH 3T3 cells . The relative activity ofthe transgenes
was reversed with the two shortest constructs, CoICAT1.7
and CoICAT0.9, in which the CAT activity was four- to
fivefold lower in ROS 17/2.8 than inNIH-3T3 cells (Fig. 2) .
One possible explanation for this is that, although NIH-3T3
cells cannot use the upstream regulatory domains, they use
promoter elements near the transcription start site more
effectively than ROS 17/2.8 cells .
In transgenic mice the expression of the full-length
CoICAT3 .6 construct followed the expected distribution be-
tween the high and low collagen-producing tissues . CAT ex-
pression in the osteoblast-rich layer of bone was 20- to 30-
foldhigher than thatin skin and three- to fourfold higher than
that in adjacent periosteum (Table 1I) . Not surprisingly, high
CAT activity was present in extracts from molar tooth germs
and tendon . The former is attributed to highly differentiated
dentin-producing odontoblasts, which represent 10 to 20
percent of the cells in dental papillae of dissected tooth
germs, and the latter to uniquely specialized tendon fibro-
blasts which produce large amounts of type I collagen . Ac-
curate quantitation of CAT activity in the high collagen
producing cells of calvaria and tooth germ, however, is not
possible because they contain a mixture of osseous and
fibroblastic cells. Similarly, skin is a mixture of dermal
fibroblasts and noncollagen producing epithelial cells. How-
ever, an appreciation of the preferred expression of the
CoICAT3 .6 construct in osseous cells versus fibroblasts was
revealed by immunohistochemistry (Fig. 7) . The layer of
differentiated osteoblasts lining the mineralized matrix ofthe
calvarial bone was stained for CAT much stronger than the
periosteal cells, confirming the higher level oftype I collagen
synthesis in osteoblasts compared to periosteum (Rowe and
Kream, 1982) . Similarly, two distinct cell populations were
observed in tooth germs : a single layer of differentiated
odontoblasts, actively engaged in type I collagen synthesis
(Ruch, 1985), and the adjacent population of less active
precursors within the dental papilla .
While the RNase protection experiments showed the cor-
rect transcriptional initiation ofthe chimeric gene promoter,
the relative intensities of the 115- and 371-bp bands indicate
that the level ofmRNA accumulation from the transgene is
significantly less than the endogenous gene . The basis for
this difference is likely to be multifold and very important
for a full understanding ofthe complexity oftype I collagen
regulation in specialized connective tissues. Candidate sites
234that could account for the observed differences include:
(a) The difference in stability of COLIA1 and transgene
mRNAs; (b) the presence of regulatory sequences that in-
crease basal activity, such as those described in the first in-
tron (Choi et al., 1991), or locus control regions which con-
fer copy number dependence of the transgene activity
(Grosveld et al., 1987); (c) other tissue-specific sequences
which are still absent from the test construct. Although the
leveloftransgene mRNAs suggests that thefull complement
of regulatory elements couldbe missing from our construct,
theCAT enzyme and immunofluorescence data clearly indi-
cate that it reflects the microheterogeneity of expression in
differentiated collagen producing cells.
The present results indicate subtle inconsistencies in the
effect ofpromoter deletionsdependingon which osteoblastic
cell line is used to expresstheconstruct(Figs. 2 and3). This
emphasizes thedependence oftransfection studieson thecell
type used. Although the osteoblast-like cell lines, such as
ROS 17/2.8, Py-la, and MC3T3-El, are useful for mapping
of cis-active DNA elements, theresults should be verified in
transgenic animals, since differences in transgene activity in
thesetwosystemswere observed. Forexample, Fig. 8 demon-
strates that the transgene is expressed significantly higher in
calvarial bone of transgenic mouse than in ROS 17/2 .8 cells
when normalized to endogenous collagen mRNA. This ob-
servationmay reflect differences of the transgene chromatin
structure in transfected cells versus that in transgennc animals,
sincethelatter hasthesame developmentalhistoryas theen-
dogenous gene (Palmiter et al., 1991). Appreciating the
differences between the cell culture and the transgennc ani-
mal model systems is essential before embarking on studies
of the DNA response elements that control differentiation,
hormonal regulation or tissue repair. The cell lines and
transgenc mice that have been established as part of this
work will be of greatvalue to investigators interested in the
fine controlofthe type Icollagen gene in a differentiated cel-
lular environment.
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